STAT3 and neoplasm: Our study demonstrated that either KD, or inhibition of STAT3 with small molecule inhibitor WP1066, significantly increases apoptosis and suppresses subcutaneous MB tumor growth with a concomitant increase in the survival of tumor-bearing mice in vivo.